Delisting risk
Tempest Therapeutics (TPST)
Develops in vivo CAR-T candidates for autoimmune disease and cancer.
$1.10
Pre-market0.00 (0.00%)
At close$1.10(+4.76%)
Something off on this page? Send us feedback.
Next report
Nov 4, 2026
estimated · in 62 days
EPS estimate
−$0.35
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
May '25Aug '25Nov '25Mar '26May '26May '26Aug '26Nov '26
Reported−$3.16−$2.07−$0.79−$0.62−$2.53−$0.51−$0.34Pending
Estimate−$3.71−$3.23−$3.27−$0.62−$0.28−$0.28−$0.30−$0.35
Surprise+14.8%+35.9%+75.8%0.0%−803.6%−82.1%−13.3%—
RevenueReportedEstimate
May '25Aug '25Nov '25Mar '26May '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.35 | — | — |
| Aug 2026 | −$0.30 | −$0.34 | −13.3% |
| May 2026 | −$0.28 | −$0.51 | −82.1% |
| May 2026 | −$0.28 | −$2.53 | −803.6% |
| Mar 2026 | −$0.62 | −$0.62 | 0.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Nov 2025 | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | −$0.35 | — | — | — | — | — | — |
| Aug 13, 2026 | −$0.30 | −$0.34 | −13.3% | — | — | — | −13.7% |
| May 15, 2026 | −$0.28 | −$0.51 | −82.1% | — | — | — | −0.6% |
| May 14, 2026 | −$0.28 | −$2.53 | −803.6% | — | — | — | −12.4% |
| Mar 31, 2026 | −$0.62 | −$0.62 | 0.0% | — | — | — | −1.2% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Nov 5, 2025 | |||||||
| Aug 11, 2025 | |||||||
| May 13, 2025 | |||||||
| Mar 27, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 19, 2024 | |||||||
| Nov 8, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 10, 2023 | |||||||
| Mar 22, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 15, 2022 | |||||||
| May 13, 2022 | |||||||
| Mar 29, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Aug 12, 2021 | |||||||
| May 13, 2021 | |||||||
| Mar 29, 2021 | |||||||
| Nov 9, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 8, 2020 | |||||||
| Mar 11, 2020 | |||||||
| Nov 13, 2019 | |||||||
| Aug 12, 2019 | |||||||
| May 15, 2019 | |||||||
| Mar 29, 2019 | |||||||
| Nov 10, 2018 | |||||||
| Aug 9, 2018 | |||||||
| May 3, 2018 | |||||||
| Mar 15, 2018 | |||||||
| Nov 2, 2017 | |||||||
| Aug 3, 2017 | |||||||
| May 9, 2017 | |||||||
| Mar 2, 2017 | |||||||
| Nov 3, 2016 | |||||||
| Aug 4, 2016 | |||||||
| May 5, 2016 | |||||||
| Feb 25, 2016 | |||||||
| Nov 5, 2015 | |||||||